中证500成长ETF华夏（159620）业绩比较基准为中证智选500成长创新策略指数收益率，管理人为华夏 基金管理有限公司，基金经理为荣膺，成立（2022-07-19）以来回报为26.34%，近一个月回报为 9.61%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 1月14日，截止午间收盘，中证500成长ETF华夏（159620）涨2.30%，报1.291元，成交额58.20万元。中 证500成长ETF华夏（159620）重仓股方面，长川科技截止午盘涨6.39%，科沃斯涨1.92%，百济神州涨 1.20%，广合科技涨1.90%，九号公司跌0.18%，晶晨股份涨3.40%，瑞芯微涨2.73%，恒玄科技涨 4.54%，三美股份涨0.37%，中瓷电子涨1.14%。 来源：新浪基金∞工作室 ...

1月14日，恒玄科技涨5.07%，截至发稿，报242.50元/股，成交6.49亿元，换手率1.63%，总市值409.08 亿元。 责任编辑：小浪快报 数据显示，易米基金旗下1只基金重仓恒玄科技。易米开泰混合A（015703）三季度持有股数7800股， 占基金净值比例为5.07%，位居第二大重仓股。根据测算，今日浮盈赚取约9.13万元。 易米开泰混合A（015703）成立日期2022年11月8日，最新规模3813.98万。今年以来收益3.54%，同类 排名4296/8838；近一年收益33.83%，同类排名4114/8089；成立以来亏损0.23%。 易米开泰混合A（015703）基金经理为魏鑫、贺文奇。 截至发稿，魏鑫累计任职时间1年161天，现任基金资产总规模3.89亿元，任职期间最佳基金回报 88.63%， 任职期间最差基金回报1.49%。 贺文奇累计任职时间3年12天，现任基金资产总规模4575.29万元，任职期间最佳基金回报47.02%， 任 职期间最差基金回报0.33%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理 ...

Market Overview - A-shares experienced a collective pullback on January 13, with the Shanghai Composite Index ending a 17-day winning streak, closing down 0.64% [1] - The total trading volume in the Shanghai and Shenzhen markets reached a historical high of 3.7 trillion [1] Sector Performance - Significant declines were observed in various sectors, including commercial aerospace, satellite internet, and military industries, with many stocks dropping over 8% [3] - The large aircraft and military sectors also faced downturns, with several stocks hitting the daily limit down [3] - The commercial aerospace index fell by 6.15%, with a net outflow of 230.78 billion [4] Individual Stock Movements - Over 1,600 stocks rose, with more than 70 stocks hitting the daily limit up, while the commercial aerospace sector saw over 60 stocks limit down or drop more than 10% [3] - Specific stocks such as Aerospace Electronics and Beidou Star Communication experienced significant declines, with many stocks in the sector down by nearly 10% [7] Investment Insights - Analysts suggest that the current market sentiment may indicate a nearing peak, with potential for further structural upward trends despite short-term volatility [12] - Key investment strategies include avoiding speculative risks in popular sectors, focusing on policy-driven industries, and maintaining diversified portfolios to balance risk and return [14] - The emphasis is on sectors with strong earnings growth and valuation alignment, particularly in technology manufacturing and innovative healthcare [14]

1月13日，A股市场AI应用概念股尾盘快速下挫，其中，恒玄科技跌超9%，广和通跌超8%，乐鑫科技跌 超6%，芒果超媒、拓维信息、瑞芯微、云从科技、虹软科技、润和软件跌超5%。 | 代码 | 名称 | | 涨幅% ↑ | 总市值 | 年初至今涨幅% | | --- | --- | --- | --- | --- | --- | | 688608 | 恒玄科技 | 1 | -9.63 | 389亿 | 1.74 | | 300638 | 厂和通 | 1 | -8.17 | 297亿 | 11.54 | | 688018 | 乐鑫科技 | 兼 | -6.33 | 297亿 | 4.39 | | 300413 | 芒果超媒 | 1 | -5.94 | 522亿 | 14.21 | | 002261 | 拓维信息 | मे | -5.83 | 438亿 | 4.92 | | 603893 | 瑞芯微 | 来 | -5.59 | 783亿 | 4.32 | | 688327 | 云从科技-l x | | -5.57 | 174亿 | 16.77 | | 688088 | 虹软科技 | | -5.53 | 225亿 | 1 ...

格隆汇1月13日｜A股市场AI应用概念股尾盘快速下挫，其中，恒玄科技跌超9%，广和通跌超8%，乐鑫 科技跌超6%，芒果超媒、拓维信息、瑞芯微、云从科技、虹软科技、润和软件跌超5%。 ...

中国经济网北京1月13日讯 恒玄科技(688608.SH)昨晚披露了关于股东减持股份计划公告。 截至公告披露日，恒玄科技控股股东之一致行动人股东宁波梅山保税港区百碧富创业投资合伙企业 （有限合伙）（以下简称"宁波百碧富"）、宁波梅山保税港区千碧富创业投资合伙企业（有限合伙） （以下简称"宁波千碧富"）和宁波梅山保税港区亿碧富创业投资合伙企业（有限合伙）（以下简称"宁 波亿碧富"）合计持有公司股份10,373,706股，持股比例6.15%。上述股份均为公司首次公开发行前取得 的股份，已于2023年12月18日解除限售并上市流通。 公司持股5%以上股东RunYuanCapitalILimited（以下简称"RunYuanI"）和一致行动人 RunYuanCapitalIILimited（以下简称"RunYuanII"）合计持有公司股份13,435,030股，合计占公司总股本 7.96%。上述股份均为公司首次公开发行前取得的股份，已于2021年12月16日解除限售并上市流通。 因自身资金需求，公司控股股东之一致行动人宁波百碧富、宁波千碧富、宁波亿碧富拟通过集中竞 价和大宗交易方式合计减持公司股份不超过253.040 ...

昨日大涨8.5%的恒玄科技(688608.SH)午间收跌近8%，现报235.33元，总市值跌破400亿元关口。消息上，恒玄科技发布股份减持公告，股东Run Yuan Capital I Limited,Run Yuan Capital II Limited，宁波梅山保税港区百碧富创业投资合伙企业(有限合伙),宁波梅山保税港区千碧富创业投资合伙企业(有限合伙),宁波梅 山保税港区亿碧富创业投资合伙企业(有限合伙)拟减持公司股份不超过506.08万股，减持比例不超过公司总股本的3%。此外据悉，该公司近三年累计发布减 持计划公告4次。 ...

Group 1 - Weiteou signed a strategic cooperation agreement with Qiteng Robotics to focus on safety upgrades in high-risk industries, leveraging new materials and robotics [1] - Dongfang Caifu's subsidiary received approval from the CSRC to issue subordinate bonds totaling up to 20 billion yuan [2] - Haibo Zhongke's controlling shareholder plans to reduce holdings by up to 2.98% of the company's shares [3] Group 2 - Shengyang Technology's subsidiary FTA is expanding into the foreign satellite internet terminal business, which is still in the early commercialization stage [4] - Cangge Mining expects a net profit increase of 43.41%-53.1% for 2025, projecting a profit of 3.7-3.95 billion yuan [5] - Jinlongyu plans to invest approximately 1.2 billion yuan to build a production line for solid-state batteries with an annual capacity of 2 GWh [6] Group 3 - Shengda Resources intends to acquire a 55% stake in Guangxi Laibin Jinshi Mining for 269.5 million yuan [7] - Zhifei Biological's CA111 injection has entered Phase I clinical trials, targeting diabetes and weight loss treatment [8] - Qusleep Technology's specific shareholders plan to reduce their holdings by up to 2.58% of the company's shares [9] Group 4 - Innovation Medical's subsidiary has a product expected to generate revenue of 114,000 yuan in 2025 [11] - Blue Ocean Cursor noted that AI-driven revenue currently constitutes a small portion of overall revenue [12] - *ST Yanshi anticipates a loss for the 2025 fiscal year, with revenue expected to be below 300 million yuan [13] Group 5 - ST Yishite will lift risk warnings and change its stock name, resuming trading on January 14 [14] - Shaoyang Hydraulic clarified that its products do not directly serve commercial aerospace clients [15] - Boss Electric plans to invest 100 million yuan in Youte Smart Kitchen to deepen strategic cooperation [16] Group 6 - Guo An Da's controlling shareholder plans to reduce holdings by up to 3% of the company's shares [17] - *ST Mingjia has lifted the delisting risk warning following the completion of its restructuring plan [18] - Haixiang Pharmaceutical signed an innovative drug cooperation agreement with Wanbangde Pharmaceutical [19] Group 7 - Palm Holdings plans to transfer stakes in two project companies for debt compensation, amounting to 258 million yuan [20] - Bohai Leasing's subsidiary Avolon is projected to have a fleet of 1,132 aircraft by the end of 2025 [21] - Zhenyou Technology reported that satellite internet revenue accounted for approximately 7.15% of total revenue in the first three quarters of 2025 [22] Group 8 - Blue Arrow Electronics intends to acquire at least 51% of Chengdu Xinyi Technology [23] - Shunhao Co. stated that its investment in Tianshu Chuangxin will have a minimal impact on its 2025 performance [24][25] - Baichuan Co.'s deputy general manager plans to reduce holdings by up to 0.65% of the company's shares [26] Group 9 - Zhewen Interconnect reported that its GEO business has not yet formed a mature profit model [27] - XW Communication's controlling shareholder plans to reduce holdings by up to 1% of the company's shares [28] - Electric Science Digital indicated that its satellite communication products are not its main business [29] Group 10 - Bojun Technology expects a net profit increase of 35%-65% for 2025, projecting a profit of 828-1,012 million yuan [30] - Rongchang Bio signed a licensing agreement for the RC148 drug with AbbVie, with an initial payment of 650 million USD [31] - Guoxin Technology's state investment fund plans to reduce holdings by up to 2.37% of the company's shares [32] Group 11 - Hengxuan Technology's controlling shareholder plans to reduce holdings by up to 3% of the company's shares [33][34] - *ST Chengchang announced a stock suspension for investigation due to abnormal trading [35] - Zhongji Xuchuang's subsidiary plans to issue warrants to incentivize its core team [36] Group 12 - Zhuoshengwei expects a net loss of 255-295 million yuan for 2025 [37] - Pingtan Development anticipates a loss for the 2025 fiscal year [38] - Nanjing Bank's major shareholder increased its stake by 123.472 million shares [39] Group 13 - Jingao Technology expects a net loss of 4.5-4.8 billion yuan for 2025 [40] - Mingyang Smart plans to acquire control of Dehua Company, with stock suspension [41] - Vanadium Titanium Co. anticipates a loss for the 2025 fiscal year [42][43] Group 14 - Tianzhihang announced a delay in its "Smart Medical Center Construction Project" [44]

21智讯1月13日电，恒玄科技公告，公司控股股东之一致行动人宁波百碧富创业投资合伙企业（有限合 伙）、宁波千碧富创业投资合伙企业（有限合伙）和宁波亿碧富创业投资合伙企业（有限合伙）拟通过 集中竞价和大宗交易方式合计减持公司股份不超过253.0406万股，即不超过公司目前总股本的1.50%。 同时，持股5%以上股东RunYuanCapitalILimited及其一致行动人RunYuanCapitalIILimited也拟通过相同方 式合计减持公司股份不超过253.0406万股，即不超过公司目前总股本的1.50%。上述减持计划均因股东 自身资金安排，实施期间为2026年2月3日至2026年4月30日，减持价格将按市场价格确定。若公司发生 股本除权、除息事项，减持股份数量将相应调整。本次减持不会导致公司控制权变化，也不会对公司持 续经营产生重大影响。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 ● 股东持股的基本情况 截至本公告披露日，恒玄科技（上海）股份有限公司（以下简称"公司"） 控股股东之一致行动人股东 宁波梅山保税港区百碧富创业投资合伙企业（有限合伙）（以下简称"宁波百碧富"）、宁波梅山保税港 区千碧富创业投资合伙企业（有限合伙）（以下简称"宁波千碧富"）和宁波梅山保税港区亿碧富创业投 资合伙企业（有限合伙）（以下简称"宁波亿碧富"）合计持有公司股份10,373,706股，持股比例6.15%。 上述股份均为公司首次公开发行前取得的股份，已于2023年12月18日解除限售并上市流通。 公司持股5%以上股东Run Yuan Capital I Limited（以下简称"Run Yuan I"）和一致行动人Run Yuan Capital II Limited（以下简称"Run Yuan II"）合计持有公司股份13,435,030股，合计占公司总股本7.96%。上述股 份均为公司首次公开发行前取得的股份，已于2021年12月16日解除限售并上市流通。 ● 减持计划的主要内容 因自身资金需求，公司控股股东之一致行动人宁波百碧富、宁波千碧富、宁波亿碧 ...